[1]
Łukasz Ćmok, “TARGETING THE SIGMA-1/NMDA RECEPTOR COMPLEX TO AMELIORATE COGNITIVE DEFICITS AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA”, IJITSS, vol. 3, no. 1(49), Mar. 2026, doi: 10.31435/ijitss.1(49).2026.5596.